148 related articles for article (PubMed ID: 9042982)
1. One-day intensified lansoprazole-quadruple therapy for cure of Helicobacter pylori infection.
de Boer WA; van Etten RJ; Schade RW; Ouwehand ME; Schneeberger PM; van Unnik AJ; Tytgat GN
Aliment Pharmacol Ther; 1997 Feb; 11(1):109-12. PubMed ID: 9042982
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness of quadruple therapy using lansoprazole, instead of omeprazole, in curing Helicobacter pylori infection.
de Boer WA; van Etten RJ; Lai JY; Schneeberger PM; van de Wouw BA; Driessen WM
Helicobacter; 1996 Sep; 1(3):145-50. PubMed ID: 9398895
[TBL] [Abstract][Full Text] [Related]
3. Bismuth-based quadruple therapy for Helicobacter pylori - a single triple capsule plus lansoprazole.
De Boer WA; Van Etten RJ; Van De Wouw BA; Schneeberger PM; Van Oijen AH; Jansen JB
Aliment Pharmacol Ther; 2000 Jan; 14(1):85-9. PubMed ID: 10632650
[TBL] [Abstract][Full Text] [Related]
4. Lansoprazole quadruple therapy is effective in curing Helicobacter pylori infection.
Korman MG; Bolin TD; Nicholson FB; Engelman JL
Helicobacter; 1998 Sep; 3(3):202-5. PubMed ID: 9731992
[TBL] [Abstract][Full Text] [Related]
5. Four-day lansoprazole-quadruple therapy in the routine treatment of Helicobacter pylori infection.
de Boer WA; van Etten RJ; Schneeberger PM
Neth J Med; 1998 Jan; 52(1):10-5. PubMed ID: 9573736
[TBL] [Abstract][Full Text] [Related]
6. Four-day quadruple therapy as a routine treatment for Helicobacter pylori infection.
de Boer SY; Siem TH
Aliment Pharmacol Ther; 1997 Dec; 11(6):1119-21. PubMed ID: 9663839
[TBL] [Abstract][Full Text] [Related]
7. Two-day 'weekend' lansoprazole-quadruple therapy for Helicobacter pylori infection.
de Boer WA; van Etten RJ; Coremans A; Schneeberger PM
Aliment Pharmacol Ther; 1998 Jan; 12(1):77-81. PubMed ID: 9692705
[TBL] [Abstract][Full Text] [Related]
8. Bismuth subsalicylate instead of metronidazole with lansoprazole and clarithromycin for Helicobacter pylori infection: a randomized trial.
Chey WD; Fisher L; Elta GH; Barnett JL; Nostrant T; DelValle J; Hasler WL; Scheiman JM
Am J Gastroenterol; 1997 Sep; 92(9):1483-6. PubMed ID: 9317068
[TBL] [Abstract][Full Text] [Related]
9. Anti-Helicobacter pylori treatment in bleeding ulcers: randomized controlled trial comparing 2-day versus 7-day bismuth quadruple therapy.
Kung NN; Sung JJ; Yuen NW; Ng PW; Wong KC; Chung EC; Lim BH; Choi CH; Li TH; Ma HC; Kwok SP
Am J Gastroenterol; 1997 Mar; 92(3):438-41. PubMed ID: 9068464
[TBL] [Abstract][Full Text] [Related]
10. Comparison of four-day and seven-day pantoprazole-based quadruple therapy as a routine treatment for Helicobacter pylori infection.
de Boer SY; v d Meeberg PC; Siem H; de Boer WA
Neth J Med; 2003 Jun; 61(6):218-22. PubMed ID: 12956102
[TBL] [Abstract][Full Text] [Related]
11. 4-day lansoprazole quadruple therapy: a highly effective cure for Helicobacter pylori infection.
de Boer WA; van Etten RJ; Schade RW; Ouwehand ME; Schneeberger PM; Tytgat GN
Am J Gastroenterol; 1996 Sep; 91(9):1778-82. PubMed ID: 8792697
[TBL] [Abstract][Full Text] [Related]
12. Twice daily (mid-day and evening) quadruple therapy for H. pylori infection in the United States.
Graham DY; Belson G; Abudayyeh S; Osato MS; Dore MP; El-Zimaity HM
Dig Liver Dis; 2004 Jun; 36(6):384-7. PubMed ID: 15248377
[TBL] [Abstract][Full Text] [Related]
13. Lansoprazole triple therapy for Helicobacter pylori--is 5 days enough?
O'Connor HJ; McLoughlin R; Kelly S; Laundon J; Cunnane K
Aliment Pharmacol Ther; 1998 Mar; 12(3):273-6. PubMed ID: 9570262
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the efficacy of 1-day high-dose quadruple therapy versus 7-day triple therapy for treatment of Helicobacter pylori infection.
Zheng Q; Pan Y; Zhang L; Xiao SD
Chin J Dig Dis; 2005; 6(4):202-5. PubMed ID: 16246231
[TBL] [Abstract][Full Text] [Related]
15. A randomized trial of lansoprazole, amoxycillin, and clarithromycin versus lansoprazole, bismuth, metronidazole and tetracycline in the retreatment of patients failing initial Helicobacter pylori therapy.
Magaret N; Burm M; Faigel D; Kelly C; Peterson W; Fennerty MB
Dig Dis; 2001; 19(2):174-8. PubMed ID: 11549829
[TBL] [Abstract][Full Text] [Related]
16. A one-week quadruple eradication regimen for Helicobacter pylori in routine clinical practice.
Vautier G; Scott BB
Aliment Pharmacol Ther; 1997 Feb; 11(1):107-8. PubMed ID: 9042981
[TBL] [Abstract][Full Text] [Related]
17. Comparison of two 3-day Helicobacter pylori eradication regimens with a standard 1-week regimen.
Grimley CE; Penny A; O'sullivan M; Shebani M; Lismore JR; Cross R; Illing RC; Loft DE; Nwokolo CU
Aliment Pharmacol Ther; 1999 Jul; 13(7):869-73. PubMed ID: 10383520
[TBL] [Abstract][Full Text] [Related]
18. One-week ranitidine bismuth citrate versus colloidal bismuth subcitrate-based anti-Helicobacter triple therapy: a prospective randomized controlled trial.
Kung NN; Sung JJ; Yuen NW; Li TH; Ng PW; Lai WM; Lui YH; Lam KN; Choi CH; Leung EM
Am J Gastroenterol; 1999 Mar; 94(3):721-4. PubMed ID: 10086657
[TBL] [Abstract][Full Text] [Related]
19. The influence of pretreatment on cure rates of Helicobacter pylori eradication.
Janssen MJ; Laheij RJ; Jansen JB; de Boer WA
Neth J Med; 2004 Jun; 62(6):192-6. PubMed ID: 15460498
[TBL] [Abstract][Full Text] [Related]
20. The efficacy of bismuth containing quadruple therapy as a first-line treatment option for Helicobacter pylori.
Uygun A; Kadayifci A; Safali M; Ilgan S; Bagci S
J Dig Dis; 2007 Nov; 8(4):211-5. PubMed ID: 17970879
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
